Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 0.1% Tacrolimus Ointment in the Treatment of Chronic Allergic Contact Dermatitis

NCT00667056 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00667056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00667056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 0.1% Tacrolimus Ointment in the Treatment of Chronic Allergic Contact Dermatitis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2004
Completion date
December 31, 2004
Enrollment
98 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis